Human Phenotype Project Study Protocol

Status Recruiting

Clinical Trial Summary

This is a prospective study aimed at recruiting 30,000 individuals, aged 40-70 years old, and following them longitudinally for 25 years with repeated measurements. The basic follow-up frame will include a visit to the Clinical Test Center (CTC) every two years and a phone interview every other year (on uneven years). Sample collection and biobanking will be performed every two years and online questionnaires will be filled out on an annual basis. The primary goals are to study the variation observed across different individuals in disease susceptibility, clinical phenotypes, and therapeutic responses. The study aims at studying the complex interplay and relative contribution of different omics, physiological characteristics and lifestyle on disease pathogenesis and progression and to evaluate how these effects are mediated.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Adult Disease

Clinical Trial Details

NCT number	NCT05817734
Study type	Observational
Source	Weizmann Institute of Science
Contact	Eran Segal, Prof.
Phone	972-8-9343266
Email	Eran.Segal@weizmann.ac.il
Status	Recruiting
Phase
Start date	October 1, 2018
Completion date	December 31, 2045

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04804306` - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Completed	`NCT02309164` - The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).	N/A
Unknown status	`NCT01614353` - Medication-taking Preferences & Practices of Patients With Chronic Conditions	N/A
Completed	`NCT01345981` - A Comparison of Pain Severity on Injection of MCT/LCT Propofol Between Lidocaine 20 mg, 40 mg, and Without Lidocaine.	N/A
Recruiting	`NCT06403436` - A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors	Phase 1
Completed	`NCT04291417` - Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W
Recruiting	`NCT04643015` - New Ways of Doing Magnetic Resonance Imaging in Children and Adults
Active, not recruiting	`NCT03986879` - Relationship of the Physical Activity Practice and Its Different Domains With Cardiac Autonomic Modulation
Completed	`NCT03119220` - Applying a Stress Framework to Health Behavior Change: A Fitbit Study	N/A
Recruiting	`NCT04855929` - A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients With Advanced Cancer.	Phase 1
Completed	`NCT01346384` - Time - Related Cuff Pressure and Volume of the Laryngeal Tube With the Use of Nitrous Oxide	N/A
Completed	`NCT03535441` - HMGB1 Release From Hemorrhagic Shock Patients
Completed	`NCT04819035` - Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital
Completed	`NCT04958499` - Effectiveness of Bio-Healthy Park on Adult	N/A
Recruiting	`NCT06007092` - Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer	Phase 1/Phase 2
Completed	`NCT04353388` - Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University
Terminated	`NCT04276714` - Revofit™ System Evaluation on Residual Limb Pain in Amputee Patients	N/A
Terminated	`NCT05641324` - A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)	Phase 1
Recruiting	`NCT05578872` - A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).	Phase 1/Phase 2
Suspended	`NCT03172897` - Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients	Phase 4